High-content screening for drugs against cancer and age-related diseases
AssigneeSenex Biotechnology, Inc.
InventorsBey-Dih Chang, Igor Roninson
Life of this patent
Estimating the term…
Abstract
The invention relates to methods for high-throughput screening for compounds that modulate cell growth or promoter activity. The invention provides the use of cell lines with properly regulated promoter-reporter expression, suitable for high-throughput screening. More particularly, the invention relates to such screening to identify compounds that affect cell growth and/or that modulate the effect of cell cycle arrest on the function of a promoter that is responsive to cell cycle inhibition.
Claims25
A method for identifying a bioactive substance that has a differential effect on the growth or survival of proliferating and growth-arrested cells comprising contacting cells comprising an inducible promoter operatively associated with a gene that encodes a protein that directly or indirectly inhibits cell cycle progression with a test bioactive substance under conditions in which the inducible promoter is activated or not activated and assaying for total cell number or total cell mass, wherein the test bioactive substance is identified as a substance that has a differential effect on the growth or survival of proliferating and growth-arrested cells if the total cell number or total cell mass under conditions in which the inducible promoter is activated or not activated is different in the presence of the bioactive substance compared to the total cell number or total cell mass in the absence of the bioactive substance.
A method for identifying a bioactive substance that modulates the effect of cell cycle inhibition on the function of a promoter that is responsive to cell cycle inhibition comprising contacting cells comprising a first inducible promoter operatively associated with a gene that encodes a protein that directly or indirectly inhibits cell cycle progression and a second promoter responsive to cell cycle inhibition and operatively associated with a gene encoding a detectable protein with test bioactive substance under conditions in which the first promoter is activated or not activated, assaying for total cell number, assaying for the detectable protein, determining the ratio of detectable protein to the total cell number, wherein the test bioactive substance is identified as a substance that modulates the effect of cell cycle arrest on transcription if the ratio of detectable protein to the total cell number under conditions in which the first promoter is activated or not activated is different in the presence of the bioactive substance compared to the ratio in the absence of the bioactive substance.
The method according to claim 28, wherein the fluorescent protein is green fluorescent protein.
A method for identifying a bioactive substance that has an effect either on cell growth or a promoter responsive to cell cycle inhibition comprising contacting cells comprising a first inducible promoter operatively associated with a gene that encodes a protein that directly or indirectly inhibits cell cycle progression and a second promoter responsive to cell cycle inhibition and operatively associated with a gene encoding a detectable protein with test bioactive substance under conditions in which the first promoter is activated or not activated, assaying for total cell number, assaying for the detectable protein, determining the ratio of detectable protein to the total cell number, wherein the test bioactive substance is identified as a substance that has an effect on cell growth if the total cell number under conditions in which the first promoter is activated or not activated is different in the presence of the bioactive substance than in the absence of the bioactive substance, and as a substance that has an effect on a promoter responsive to cell cycle inhibition if the ratio of detectable protein to the total cell number under conditions in which the first promoter is activated or not activated is different in the presence of the bioactive substance compared to the ratio in the absence of the bioactive substance.
Dependencies are inferred from the claim text.